Atimos® (Formoterol)
Atimos is available in a pMDI, delivering 100 inhalations of 12 micrograms of formoterol fumarate dihydrate per device.1–3
As part of a respiratory portfolio optimisation process, to better align with UK treatment guidelines, Atimos will be discontinued in Q4 2026. The treatment plans of patients currently prescribed this product will need to be reviewed.
Find out more about the discontinuation here, and learn about recommendations for alternative treatments below.
